Dayita Banerjee/ LinkedIn
Jul 26, 2026, 08:51
Dayita Banerjee: Presenting New Insights in Fibrinolysis Research at ISTH 2026
Dayita Banerjee, PHD Student at Michigan State University, shared a post on LinkedIn:
“Such an exciting time attending and presenting at my first International Society on Thrombosis and Haemostasis (ISTH) meeting.
Thank you to those of you who came by my poster, ‘Tissue plasminogen activator drives acetaminophen-induced hepatotoxicity independently of plasminogen.’
It was great to connect with you all in Paris. Looking forward to staying in touch.”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 10:00Benjamin Tur: Putting Iron Deficiency Anemia on the Global Agenda at the Paris Peace Forum’s Child Summit
-
Nov 14, 2026, 09:48Jack Shuang Hou: FDA Approves Bayer’s Sunharbo – First Factor XIa Inhibitor for Secondary Stroke Prevention
-
Nov 14, 2026, 09:42Samwel Mikaye: What Every Patient Should Know About DVT Symptoms and Treatment
-
Nov 14, 2026, 09:37Chronic Preoperative Corticosteroid Use and Postoperative Venous Thromboembolism Risk – Thrombosis and Haemostasis Journal
-
Nov 14, 2026, 09:30Ney Carter Borges: Vulnerable Plaque – Imaging and Clinical Significance
-
Nov 14, 2026, 09:25Carmelo Raffo: How Much Antithrombotic Therapy is Truly Necessary after LAAC?
-
Nov 14, 2026, 09:19Mary Cushman: Excellent to Have Jordan Shavit Visit Us for a Virtual Lab Meeting Today
-
Nov 14, 2026, 09:15Chancellor Donald: Heading to ASH 2026 in New Orleans? Let’s Connect on Faculty Opportunities at Tulane
-
Nov 14, 2026, 09:11Sajja Venkatesh: FDA Approved Asundexian, the First Factor XIa Inhibitor